@article {10348,
	title = {Adipocytokines and psoriasis: Insights into mechanisms linking obesity and inflammation to psoriasis.},
	journal = {World J Dermatol},
	volume = {2},
	year = {2013},
	pages = {27-31},
	abstract = {<span style={\textquoteright}font-family: "Times New Roman",serif; font-size: 10pt; mso-fareast-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EL; mso-bidi-language: AR-SA;{\textquoteright}><span style="color: rgb(0, 0, 0);">Psoriasis has been lately seen as a potential systemic inflammatory disease associated with a range of co-morbidities exhibiting an overlapping pathology and presenting a great social health impact such as cardiovascular disease and metabolic diseases, including obesity. Adipose tissue is considered a genuine endocrine organ producing a variety of bioactive adipocytokines, such as leptin, adiponectin, resistin and visfatin, participating in physiological and pathological processes, such as energy balance, insulin sensitivity and resistance, immunity, inflammation, hematopoiesis and angiogenesis. Adipocytokines could serve as a missing link in the association between psoriasis, obesity and metabolic co-morbidities. In chronic inflammatory disease states such as psoriasis, adipocytokines may be implicated in psoriasis onset, progression, severity as well as in the pathogenesis of co-morbidities. Measuring serum adipocytokine levels in the future may be useful in predicting psoriasis severity, progression, treatment outcome and risk of any co-morbidities. Interventions to decrease pro-inflammatory adipocytokine levels could offer preventive and therapeutic options for improving psoriasis severity and protecting against its co-morbidities. Candidate strategic interventions incorporate increased physical activity, weight control and pharmacologic approaches such as metformin. However, the mechanisms underlying the actions of adipocytokines in psoriasis as well as their potential diagnostic, prognostic and/or therapeutic utility require further investigation with larger prospective, longitudinal and mechanistic studies.</span></span>},
	author = {Dalamaga, M and Papadavid, E}
}
